Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin.
Hatanaka K, Fuji S, Ikegame K, Kato R, Wake A, Hidaka M, Ito T, Inoue M, Nagatoshi Y, Takami A, Uike N, Sakamaki H, Yabe H, Morishima Y, Suzuki R, Atsuta Y, Fukuda T. Hatanaka K, et al. Among authors: uike n. Int J Hematol. 2012 Dec;96(6):773-80. doi: 10.1007/s12185-012-1209-4. Epub 2012 Nov 7. Int J Hematol. 2012. PMID: 23132596
Case-control study of leukemia and diagnostic radiation exposure.
Yuasa H, Hamajima N, Ueda R, Ohno R, Asou N, Utsunomiya A, Ogura M, Takigawa N, Ueda T, Hiraoka A, Matsuda S, Kuraishi Y, Nishikawa K, Uike N, Takeshita A, Takemoto Y, Shimazaki C, Sakamaki H, Ino T, Matsushima T, Kuriyama K, Hirai H, Naoe T, Tsubaki K, Takahashi I, et al. Yuasa H, et al. Among authors: uike n. Int J Hematol. 1997 Apr;65(3):251-61. doi: 10.1016/s0925-5710(96)00556-7. Int J Hematol. 1997. PMID: 9114596
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis.
Okamoto T, Kanamaru A, Shimazaki C, Motoji T, Takemoto Y, Takahashi M, Fukushima T, Takeshita A, Kusumoto GS, Kishimoto Y, Yorimitsu S, Tsukuda K, Uike N, Arima N, Ohno R. Okamoto T, et al. Among authors: uike n. Int J Hematol. 2000 Aug;72(2):200-5. Int J Hematol. 2000. PMID: 11039669
Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan.
Tamura K, Sawada H, Izumi Y, Fukuda T, Utsunomiya A, Ikeda S, Uike N, Tsukada J, Kawano F, Shibuya T, Gondo H, Okamura S, Suzumiya J; Kyushu Hematology Organization for Treatment (K-HOT) Study Group. Tamura K, et al. Among authors: uike n. Eur J Haematol. 2001 Sep;67(3):152-7. doi: 10.1034/j.1600-0609.2001.5790514.x. Eur J Haematol. 2001. PMID: 11737247
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.
Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y, Morishima Y, Murate T, Kasai M, Uike N, Taniwaki M, Kano Y, Ohnishi K, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K; IDEC-C2B8 Study Group in Japan. Igarashi T, et al. Among authors: uike n. Ann Oncol. 2002 Jun;13(6):928-43. doi: 10.1093/annonc/mdf155. Ann Oncol. 2002. PMID: 12123339 Free article. Clinical Trial.
178 results